Xeltis’ aortic valve one of highest peer-review oral abstracts at TCT
18 . 09 . 2018

Xeltis’ aortic valve one of highest peer-review oral abstracts at TCT

Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will present long-term preclinical on Xeltis’ aortic valve on Saturday, 22 September at 9:30am in Room 29A-B, Upper Level

Professor Spaulding will also provide an overview on Xeltis’ aortic valve replacement therapy as part of the Innovation Sessions on Friday, 21 September (Room 29A-B, Upper Level).

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year’s edition will take place September 21-25 in San Diego, California (USA).

Go back